Superiority of magnetic resonance imaging over conventional radiographs in multiple myeloma

Anticancer Research

Volumn 29, Issue 11, 2009, Pages 4745-4750

  Engelhardt, Monika ^a   Kleber, Martina ^a   Frydrychowicz, Alex ^a   Pache, Gregor ^a   Schmitt Gräff, Annette ^a   Wäsch, Ralph ^a   Durie, Brian G M ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Conventional radiological survey; MRI; Multiple myeloma; RSS

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; EPIRUBICIN; ETOPOSIDE; IMMUNOGLOBULIN KAPPA CHAIN; LENALIDOMIDE; MELPHALAN; PREDNISONE; THALIDOMIDE;

AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE ATROPHY; BONE PAIN; CANCER PATIENT; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTOLOGY; DECISION MAKING; FATIGUE; HISTOPATHOLOGY; HUMAN; MAINTENANCE THERAPY; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; PRIORITY JOURNAL; RADIODIAGNOSIS; RADIOTHERAPY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELPHALAN; MULTIPLE MYELOMA; PREDNISONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 75149155142     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Zlei M, Egert S, Wider D, Ihorst G, Wäsch R and Engelhardt M: Characterization of in vitro growth of multiple myeloma cells. Exp Hematol 35: 1550-1561, 2007.
2. Denz U, Haas P, Wäsch R, Einsele H and Engelhardt M: State of the art therapy in multiple myeloma and future perspectives. Eur J Cane 42: 1591-1600,2006.
3. Ghanem N, Lohrmann C, Engelhardt M, Pache G, UhI M, Saueressig U, Kotter and Langer M: Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol 16: 1005-1014,2006.
4. Durie BG: The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer 42: 1539-1543, 2006.
5. Abdelkefi A, Ladeb S, Torjman L, Othman TB, Lakhal A, Romdhane NB, Omri HE, Elloumi M, Belaaj H, Jeddi R, Aissaouï L, Ksouri H, Hassen AB, Msadek F, Saad A, Hsaïri M, Boukef K, Amouri A, Louzir H, Dellagi K and Abdeladhim AB: Single autologous stem cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial. Blood 111: 1805-1810, 2007.
6. Kropff M, Bisping G, Schuck E, Liebisch P, Lang N, Hentrich M, Dechow T, Kröger N, Salwender H, Metzner B, Sezer O, Engelhardt M, Wolf HH, Einsele H, Volpert S, Heinecke A, Berdel WE and Kienast J: Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma. Br J Haematol 138: 330-337, 2007.
7. Kühnemund A, Liebisch P, Bauchmüller K, zur Hausen A, Veelken H, Wäsch R and Engelhardt M: 'Light-chain (LC) escape-multiple myeloma' - an escape phenomenon from plateau phase: report of the largest patient series using LC-monitoring. J Cancer Res Clin Oncol 135: 477-484, 2009.
8. Dimopoulos MA and Terpos E for the IMWG: International myeloma working group (IMWG) consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma. Leukemia 2009 Jun 25. [Epub ahead of print].
9. Hillner BE, Siegel BA, Shields AF, Liu D, Gareen IF, Hunt E and Coleman RE: Relationship between cancer type and impact of PET/CT on intended management: findings of the national oncologic PET registry. J Nucl Med 49: 1928-1935, 2008.
10. Schaefer JF and Schlemmer HP: Total-body MR-imaging in oncology. Eur Radiol 9: 2000-2015, 2006.